Steven & Alexandra Cohen Foundation
46 Cummings Point Rd, Stamford, CT, 06902, United States
Overview
The Steven and Alexandra Cohen Foundation is dedicated to encouraging charitable giving and community involvement. They achieve this through raising awareness, and providing guidance , their grants benefit public 501(c)(3) nonprofit organizations with headquarters in the United States.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- Lykos Therapeutics
Participated · Series A · Jan 2024
Lykos Therapeutics (formerly MAPS Public Benefit Corporation) develops investigational MDMA-assisted therapy to treat post-traumatic stress disorder (PTSD). The company has completed two randomized, double-blind, placebo-controlled Phase 3 trials (MAPP1 and MAPP2) that met primary and secondary endpoints and has submitted a new drug application (NDA) to the U.S. Food and Drug Administration. If approved, the therapy would be the first psychedelic-assisted therapy for PTSD; Lykos is preparing regulatory and pre-launch activities to integrate the therapy into the healthcare system. Lykos rebranded from MAPS PBC and is transitioning from a research-stage organization to a for-profit public benefit corporation focused on commercialization; it was founded by the non-profit MAPS in 2014. The company notes Breakthrough Therapy designation for MDMA since 2017 and has requested Priority Review of its NDA, while also stating that MDMA-assisted therapy has not been approved and its safety and efficacy have not been established. The recent financing will support regulatory, pre-launch and commercialization preparations.
Team
No current team members are available.